X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15435) 15435
Newspaper Article (642) 642
Newsletter (311) 311
Book Chapter (93) 93
Conference Proceeding (88) 88
Book / eBook (44) 44
Magazine Article (41) 41
Dissertation (29) 29
Web Resource (14) 14
Trade Publication Article (11) 11
Publication (7) 7
Book Review (6) 6
Government Document (5) 5
Transcript (4) 4
Reference (3) 3
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11230) 11230
parkinson's disease (8187) 8187
male (7546) 7546
female (6894) 6894
clinical neurology (5971) 5971
middle aged (5682) 5682
aged (5649) 5649
neurosciences (5607) 5607
parkinsons-disease (4451) 4451
parkinsons disease (3237) 3237
neurology (3067) 3067
parkinson disease - diagnostic imaging (2759) 2759
dementia (2738) 2738
adult (2665) 2665
magnetic resonance imaging (2627) 2627
movement disorders (2469) 2469
neurodegenerative diseases (2466) 2466
diagnosis (2403) 2403
brain (2242) 2242
parkinson’s disease (1959) 1959
dopamine (1918) 1918
parkinson disease - physiopathology (1881) 1881
alzheimers-disease (1831) 1831
aged, 80 and over (1756) 1756
animals (1720) 1720
brain - diagnostic imaging (1720) 1720
psychiatry (1698) 1698
parkinson disease - complications (1671) 1671
neuroimaging (1654) 1654
research (1510) 1510
medical research (1492) 1492
basal ganglia (1424) 1424
diagnostic imaging (1422) 1422
alzheimer's disease (1348) 1348
parkinson disease - pathology (1348) 1348
parkinson disease - diagnosis (1334) 1334
medicine, experimental (1282) 1282
medicine & public health (1259) 1259
parkinson disease - metabolism (1250) 1250
radiology, nuclear medicine & medical imaging (1216) 1216
analysis (1215) 1215
neuropsychological tests (1177) 1177
parkinson disease (1164) 1164
positron emission tomography (1092) 1092
neurodegeneration (1077) 1077
patients (1077) 1077
brain - pathology (1073) 1073
nervous system diseases (1041) 1041
nervous system (1034) 1034
biomarkers (1019) 1019
studies (1016) 1016
progressive supranuclear palsy (1009) 1009
pet (1000) 1000
multiple system atrophy (998) 998
disease (994) 994
pathology (979) 979
cognitive ability (976) 976
risk factors (976) 976
diagnosis, differential (972) 972
brain - metabolism (970) 970
care and treatment (960) 960
medicine (942) 942
alzheimers disease (924) 924
alpha-synuclein (921) 921
tomography, emission-computed, single-photon (917) 917
lewy bodies (906) 906
medical imaging (891) 891
mild cognitive impairment (888) 888
parkinson disease - drug therapy (881) 881
case-control studies (877) 877
research article (873) 873
positron-emission tomography (861) 861
brain mapping (838) 838
atrophy (799) 799
neurons (773) 773
positron-emission-tomography (773) 773
surgery (770) 770
substantia-nigra (769) 769
neuroscience (764) 764
severity of illness index (762) 762
multidisciplinary sciences (754) 754
age (742) 742
tomography, emission-computed (740) 740
spect (727) 727
brain research (717) 717
dopamine - metabolism (715) 715
disease progression (696) 696
mri (691) 691
cognition (652) 652
science (651) 651
proteins (645) 645
tremor (645) 645
usage (641) 641
parkinson disease - therapy (639) 639
depression (636) 636
development and progression (629) 629
mental disorders (624) 624
cortex (621) 621
parkinson disease - psychology (618) 618
corpus striatum - diagnostic imaging (616) 616
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (12) 12
Baycrest Hospital - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Gerstein Science - Circulation Desk (2) 2
Online Resources - Online (2) 2
UofT at Scarborough - Stacks (2) 2
Credit Valley Hospital - Online (1) 1
Credit Valley Hospital - Reserve desk (1) 1
Providence Healthcare - Stacks (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Trillium Health Centre - Reserve desk (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16394) 16394
Japanese (118) 118
German (113) 113
French (68) 68
Spanish (64) 64
Portuguese (25) 25
Russian (24) 24
Chinese (15) 15
Danish (10) 10
Norwegian (10) 10
Dutch (9) 9
Hungarian (9) 9
Polish (9) 9
Italian (7) 7
Swedish (4) 4
Turkish (4) 4
Finnish (3) 3
Czech (2) 2
Korean (2) 2
Serbian (2) 2
Arabic (1) 1
Croatian (1) 1
Greek (1) 1
Hebrew (1) 1
Icelandic (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 2016, Volume 11, Issue 9, p. e0162460
Background Quantitative susceptibility mapping (QSM) and R2* relaxation rate mapping have demonstrated increased iron deposition in the substantia nigra of patients with idiopathic Parkinson's disease (PD... 
DIAGNOSIS | DEPOSITION | NUCLEUS | MULTIDISCIPLINARY SCIENCES | MOVEMENT | VALIDATION | QSM | RATING-SCALE | SUBSTANTIA-NIGRA | PROGRESSION | BRAIN IRON | Red Nucleus - diagnostic imaging | Thalamus - metabolism | Substantia Nigra - pathology | Humans | Middle Aged | Image Interpretation, Computer-Assisted | Male | Parkinson Disease - drug therapy | Thalamus - pathology | Substantia Nigra - metabolism | Case-Control Studies | Globus Pallidus - diagnostic imaging | Antiparkinson Agents - therapeutic use | Globus Pallidus - metabolism | Female | Parkinson Disease - metabolism | Globus Pallidus - pathology | Severity of Illness Index | Parkinson Disease - pathology | Parkinson Disease - diagnostic imaging | Levodopa - therapeutic use | Thalamus - diagnostic imaging | Brain Mapping - methods | Iron - metabolism | Thalamus - drug effects | Globus Pallidus - drug effects | Magnetic Resonance Imaging | Red Nucleus - metabolism | Substantia Nigra - drug effects | Red Nucleus - drug effects | Substantia Nigra - diagnostic imaging | Aged | Red Nucleus - pathology | Care and treatment | Usage | Diagnostic imaging | Parkinson's disease | Multiple sclerosis | Substantia nigra | Parkinsons disease | Iron | Mapping | Health physics | Substantia grisea | Nuclei | Magnetic susceptibility | Ethics | Maps | Thalamus | Levodopa | Age | Movement disorders | Dopamine receptors | Dopamine | Neurodegenerative diseases | Globus pallidus | Histology | Disease control | Patients | Neurology | Sensitivity | Brain research | Magnetic resonance imaging | Echo surveys | Magnetic permeability | Informed consent | Gene mapping
Journal Article
NeuroImage (Orlando, Fla.), ISSN 1053-8119, 2006, Volume 31, Issue 1, pp. 301 - 307
Deep brain stimulation of the subthalamic nucleus (STN DBS) has become an accepted tool for the treatment of Parkinson's disease (PD... 
FDG-PET | ACTIVATION | BASAL GANGLIA | MECHANISMS | NEUROSCIENCES | NEUROIMAGING | REPRODUCIBILITY | MOVEMENT-DISORDERS | INHIBITION | METABOLIC-CHANGES | DEEP-BRAIN-STIMULATION | CEREBRAL-BLOOD-FLOW | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Humans | Middle Aged | Gyrus Cinguli - diagnostic imaging | Male | Positron-Emission Tomography | Globus Pallidus - diagnostic imaging | Cerebral Cortex - physiopathology | Cerebellum - diagnostic imaging | Deep Brain Stimulation | Female | Neural Pathways - physiopathology | Subthalamic Nucleus - diagnostic imaging | Energy Metabolism - physiology | Globus Pallidus - physiopathology | Nerve Net - physiopathology | Parkinson Disease - rehabilitation | Parkinson Disease - diagnostic imaging | Corpus Striatum - physiopathology | Subthalamic Nucleus - physiopathology | Nerve Net - diagnostic imaging | Thalamus - diagnostic imaging | Cerebellum - physiopathology | Parkinson Disease - physiopathology | Cerebral Cortex - diagnostic imaging | Analysis of Variance | Image Processing, Computer-Assisted | Thalamus - physiopathology | Neural Pathways - diagnostic imaging | Brain Mapping | Gyrus Cinguli - physiopathology | Fluorodeoxyglucose F18 | Aged | Blood Glucose - metabolism | Corpus Striatum - diagnostic imaging | Neurosciences | Parkinson's disease | PET imaging | Drug therapy | Analysis | Studies | Electrodes | Hospitals | Medical imaging | Parkinsons disease | Tomography | Data processing
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 11/2016, Volume 11, Issue 11, p. e0165869
Journal Article
Lancet neurology, ISSN 1474-4422, 2008, Volume 7, Issue 11, pp. 1044 - 1055
... of various movement disorders. The most widely recognised finding for movement disorders has been an increase in echogenicity of the substantia nigra, an area of the midbrain that is affected in idiopathic Parkinson's disease (PD... 
Neurology | REAL-TIME SONOGRAPHY | RESTLESS LEGS SYNDROME | SUBSTANTIA-NIGRA HYPERECHOGENICITY | ADULT-ONSET DYSTONIA | BASAL GANGLIA | IN-VIVO DETECTION | IDIOPATHIC PARKINSONS-DISEASE | ESSENTIAL TREMOR | CLINICAL NEUROLOGY | BRAIN PARENCHYMA SONOGRAPHY | PROGRESSIVE SUPRANUCLEAR PALSY | Predictive Value of Tests | Basal Ganglia - diagnostic imaging | Lateral Ventricles - pathology | Humans | Basal Ganglia Cerebrovascular Disease - diagnostic imaging | Ultrasonography, Doppler, Transcranial - methods | Lateral Ventricles - diagnostic imaging | Lateral Ventricles - physiopathology | Mesencephalon - physiopathology | Movement Disorders - diagnostic imaging | Mesencephalon - pathology | Diagnosis, Differential | Parkinson Disease - pathology | Parkinson Disease - diagnostic imaging | Basal Ganglia - physiopathology | Movement Disorders - pathology | Brain - physiopathology | Basal Ganglia - pathology | Parkinson Disease - physiopathology | Mesencephalon - diagnostic imaging | Ultrasonography, Doppler, Transcranial - trends | Basal Ganglia Cerebrovascular Disease - pathology | Movement Disorders - physiopathology | Basal Ganglia Cerebrovascular Disease - physiopathology | Brain - pathology | Neuroimaging | Parkinson's disease | Scanning | Mesencephalon | Neurodegenerative diseases | Brain stem | Lentiform nucleus | Substantia nigra | Differential diagnosis | Ultrasound | Movement disorders
Journal Article